Diseases & Disorders
(G50)
IRS Verified
DX Registered
990 on File
ATLANTA NEUROSCIENCE INSTITUTE INC
Financial strength (30%)
83/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$14.1M
Total Revenue
$11.1M
Total Expenses
$19.6M
Net Assets
62
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
92.6%
Fundraising Efficiency
N/A
Operating Reserve
21.25x
Liability-to-Asset
23.9%
Revenue Diversification
81.5%
Executive Compensation
$2.2M
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
92.6% | 85.4% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.3% | 11.1% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.1% | 1.0% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.3 mo | 10.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.9% | 23.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
81.5% | 92.0% |
P10P90
|
Above median |
|
Surplus margin
Surplus as a share of revenue
|
21.8% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $14.1M | $11.1M | $19.6M | 92.6% | 62 |
| 2023 | $12.4M | $10.0M | $13.5M | 92.7% | 63 |
| 2022 | $13.1M | $11.0M | $11.2M | 94.0% | 73 |
| 2021 | $12.4M | $9.7M | N/A | — | 65 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.